X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32238) 32238
Publication (2936) 2936
Conference Proceeding (1258) 1258
Newsletter (837) 837
Newspaper Article (541) 541
Book Review (314) 314
Book Chapter (226) 226
Magazine Article (137) 137
Book / eBook (87) 87
Paper (75) 75
Trade Publication Article (73) 73
Dissertation (57) 57
Web Resource (19) 19
Government Document (17) 17
Data Set (9) 9
Reference (5) 5
Journal / eJournal (2) 2
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19318) 19318
index medicus (13555) 13555
male (9207) 9207
proton pump inhibitors (8540) 8540
female (8448) 8448
protons (7474) 7474
middle aged (6214) 6214
adult (5402) 5402
aged (4727) 4727
radiology, nuclear medicine & medical imaging (4696) 4696
gastroenterology & hepatology (4556) 4556
radiotherapy (4472) 4472
proton therapy (4211) 4211
proton pump inhibitors - therapeutic use (3655) 3655
oncology (3654) 3654
treatment outcome (3415) 3415
cancer (3343) 3343
therapy (3251) 3251
animals (3145) 3145
pharmacology & pharmacy (2849) 2849
omeprazole (2684) 2684
care and treatment (2414) 2414
gastroesophageal reflux - drug therapy (2372) 2372
risk factors (2140) 2140
proton pump inhibitor (2087) 2087
helicobacter pylori (2061) 2061
research (2031) 2031
helicobacter infections - drug therapy (1978) 1978
radiotherapy dosage (1934) 1934
gastroesophageal reflux (1928) 1928
radiation therapy (1842) 1842
aged, 80 and over (1814) 1814
dosimetry (1760) 1760
analysis (1742) 1742
health aspects (1724) 1724
adolescent (1717) 1717
medicine & public health (1709) 1709
proton beams (1703) 1703
patients (1650) 1650
drug therapy, combination (1645) 1645
anti-ulcer agents - therapeutic use (1636) 1636
radiation (1589) 1589
retrospective studies (1582) 1582
surgery (1569) 1569
lansoprazole (1475) 1475
article (1469) 1469
risk (1455) 1455
time factors (1452) 1452
magnetic resonance imaging (1442) 1442
medicine, general & internal (1396) 1396
proton pump inhibitors - adverse effects (1395) 1395
proton (1388) 1388
tumors (1363) 1363
radiation-therapy (1352) 1352
diagnosis (1301) 1301
drug therapy (1282) 1282
prospective studies (1265) 1265
child (1262) 1262
young adult (1257) 1257
proton pump inhibitors - administration & dosage (1256) 1256
management (1237) 1237
irradiation (1225) 1225
omeprazole - therapeutic use (1218) 1218
protons - therapeutic use (1218) 1218
disease (1207) 1207
usage (1199) 1199
hydrogen-ion concentration (1178) 1178
magnetic resonance spectroscopy (1148) 1148
follow-up studies (1145) 1145
monte carlo method (1137) 1137
anti-bacterial agents - therapeutic use (1086) 1086
medicine (1085) 1085
abridged index medicus (1079) 1079
engineering, biomedical (1052) 1052
gastroesophageal-reflux disease (1042) 1042
nuclear science & technology (1035) 1035
proton magnetic resonance spectroscopy (1011) 1011
gastroesophageal reflux disease (996) 996
mice (980) 980
clinical neurology (968) 968
double-blind (962) 962
2-pyridinylmethylsulfinylbenzimidazoles (961) 961
brain (961) 961
gastroesophageal reflux - diagnosis (956) 956
radiotherapy planning, computer-assisted - methods (952) 952
radiology (941) 941
medical research (937) 937
algorithms (935) 935
histamine h2 antagonists - therapeutic use (934) 934
infection (928) 928
biochemistry & molecular biology (897) 897
gastroenterology (894) 894
proton-pump inhibitors (892) 892
radiology and nuclear medicine (887) 887
gastroesophageal reflux - complications (883) 883
rats (883) 883
children (877) 877
omeprazole - analogs & derivatives (877) 877
pediatrics (873) 873
proton therapy - methods (866) 866
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (51) 51
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Physics - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32249) 32249
German (478) 478
French (380) 380
Japanese (374) 374
Russian (311) 311
Spanish (178) 178
Korean (170) 170
Chinese (71) 71
Polish (46) 46
Italian (31) 31
Hungarian (25) 25
Dutch (23) 23
Czech (19) 19
Portuguese (17) 17
Danish (11) 11
Swedish (11) 11
Norwegian (9) 9
Finnish (8) 8
Romanian (7) 7
Ukrainian (7) 7
Turkish (6) 6
Persian (3) 3
Bulgarian (2) 2
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, Radiation medicine rounds, ISBN 161705044X, Volume 1, issue 3, xii, [415]-559
Book
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 782 - 790
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
Background We report the first clinical experience and toxicity of multifield optimization (MFO) intensity modulated proton therapy (IMPT) for patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 08/2017, Volume 124, Issue 2, pp. 185 - 189
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 11/2017, Volume 123, Issue 21, pp. 4244 - 4251
BACKGROUND Existing data supporting the use of proton‐beam therapy (PBT) for limited‐stage small cell lung cancer (LS‐SCLC) are limited to a single 6‐patient... 
intensity‐modulated radiotherapy | limited stage | proton therapy | intensity‐modulated proton therapy | small cell lung cancer | intensity-modulated radiotherapy | intensity-modulated proton therapy | TRIAL | ONCOLOGY | CONCURRENT CHEMOTHERAPY | PHASE-2 | THORACIC RADIOTHERAPY | DEFINITIVE TREATMENT | Lung Neoplasms - drug therapy | Organs at Risk - radiation effects | Prospective Studies | Lung Neoplasms - mortality | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Proton Therapy - adverse effects | Lung Neoplasms - radiotherapy | Spinal Cord - radiation effects | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - drug therapy | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Small Cell Lung Carcinoma - radiotherapy | Heart - radiation effects | Aged, 80 and over | Dose Fractionation | Female | Lung - radiation effects | Esophagus - radiation effects | Radiotherapy, Intensity-Modulated - methods | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Esophagitis - etiology | Radiation Pneumonitis - epidemiology | Small Cell Lung Carcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Esophagitis - epidemiology | Small Cell Lung Carcinoma - mortality | Aged | Proton Therapy - methods | Lung cancer, Small cell | Care and treatment | Usage | Cancer patients | Proton beam radiotherapy | Heart | Anorexia | Toxicity | Lung cancer | Radiation | Cancer therapies | Cobalt | Quality | Heart diseases | Background radiation | Polybutylene terephthalates | Statistical analysis | Effusion | Small cell lung carcinoma | Etoposide | Esophagitis | Radiation therapy | Survival | Patients | Cisplatin | Esophagus | Chemotherapy | Pneumonitis | Equivalence | Carboplatin | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 01/2012, Volume 35, Issue 1, pp. 56 - 65
Aliment Pharmacol Ther 2012; 35: 56–65 Summary Background  The eradication rates following standard triple therapy for Helicobacter pylori infection are... 
METAANALYSIS | MANAGEMENT | EFFICACY | ERADICATION RATES | PROTON-PUMP INHIBITOR | KOREAN PATIENTS | PHARMACOLOGY & PHARMACY | QUADRUPLE | GASTROENTEROLOGY & HEPATOLOGY | ANTIMICROBIAL RESISTANCE | FAILURE | CONSENSUS REPORT | Humans | Middle Aged | Male | Rabeprazole | Peptic Ulcer - microbiology | Time Factors | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Republic of Korea | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Endoscopy, Gastrointestinal | Treatment Outcome | Anti-Ulcer Agents - administration & dosage | Amoxicillin - adverse effects | Aged | Helicobacter pylori - isolation & purification | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Helicobacter Infections - microbiology | Medical colleges | Medical research | Clinical trials | Standards | Helicobacter pylori | Amoxicillin | Medicine, Experimental | Medical care | Helicobacter infections | Comparative analysis | Health aspects | Quality management | Infection | Clarithromycin | Hospitals | Metronidazole
Journal Article
Gut, ISSN 0017-5749, 11/2016, Volume 65, Issue 11, pp. 1784 - 1792
Journal Article
Journal Article